✦ LIBER ✦

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies

✍ Scribed by Yi-fei Zhang; Jian-cheng Wang; Dong-yan Bian; Xuan Zhang; Qiang Zhang

Book ID: 116438273
Publisher: Elsevier Science
Year: 2010
Tongue: French
Weight: 920 KB
Volume: 74
Category: Article
ISSN: 0939-6411
DOI: 10.1016/j.ejpb.2010.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RGD-targeted paramagnetic liposomes for

RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies

✍ Wei Li; Bo Su; Shuyan Meng; Lixia Ju; Linghua Yan; Yongmei Ding; Yin Song; Wei Z 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 918 KB

A tumor vasculature targeted liposome de

A tumor vasculature targeted liposome delivery system for combretastatin A4: Design, characterization, and in vitro evaluation

✍ Ramakrishna Nallamothu; George C. Wood; Christopher B. Pattillo; Robert C. Scott 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 401 KB

Intracellular delivery of doxorubicin wi

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivo

✍ Xiao-Bing Xiong; Yue Huang; Wan-Liang LU; Xuan Zhang; Hua Zhang; Tsuneji Nagai; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Passive targeting by sterically stabilized liposomes (SSL), once combined with efficient intracellular delivery, may be a very useful strategy to improve the antitumor efficacy for the anticancer agents. The arginine-glycine-aspartic acid tripeptide (RGD) is known to serve as a recognition motif for

In vivo studies of octreotide-modified N

In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery

✍ Zou, Aifeng; Chen, Yan; Huo, Meirong; Wang, Jing; Zhang, Yong; Zhou, Jianping; Z 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB